Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical …
All Posts
Insilico Medicine Reports Benchmarks for its AI-Designed Therapeutics
Insilico Medicine has released benchmarks detailing the timelines and development metrics for 22 preclinical candidate (PCC) nominations achieved between 2021 …
AI for Protein Design: DeepMind Alum’s Startup Comes Out of Stealth with $50M
Latent Labs, a company developing AI models for computational protein design, has raised $50 million in funding and announced its …
Receptor.AI and Moexa Harness AI for SMAD3-Targeted Oncology and Fibrosis
Receptor.AI and Moexa Pharmaceuticals Limited have announced a partnership to accelerate the development of Moexa’s SMAD3 inhibitors for cancer and …
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration …
The Future of Advanced Therapeutics: Opportunities and Challenges
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These …
Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization
Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the …
Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor
Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global …
Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup
Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline …
RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy
RyboDyn, a biotechnology company targeting the “dark proteome,” has announced the discovery of a previously hidden human proteome and closed …
Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments
Arctic Therapeutics (ATx), an Icelandic drug discovery and development company, has closed an oversubscribed €26.5 million Series A financing round. …
Tempus Announces National Launch of AI-Powered Personal Health Assistant
Tempus AI, Inc. (NASDAQ: TEM) has launched olivia, an AI-enabled app designed to help patients organize and manage their health …